An assessment of the risk, cost‐effectiveness, and perceived benefits of anti‐parvovirus B19 tested blood products-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An assessment of the risk, cost‐effectiveness, and perceived benefits of anti‐parvovirus B19 tested blood products

Published:2019-04-29 Issue:7 Volume:59 Page:2352-2360
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Hoeven Loan R.¹,Janssen Mart P.¹,Lieshout‐Krikke Ryanne W.²,Molenaar‐de Backer Marijke W.³

Affiliation:

1. Donor Medicine Research Transfusion Technology Assessment DepartmentSanquin Research Amsterdam The Netherlands

2. Department of Medical AffairsSanquin Research Amsterdam The Netherlands

3. Donor Medicine Research Department of Blood‐borne InfectionsSanquin Research Amsterdam The Netherlands

Funder

Sanquin Blood Supply

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15324

Reference32 articles.

1. Clinical aspects of parvovirus B19 infection

2. Clinical presentations of parvovirus B19 infection;Servey JT;Am Fam Physician,2007

3. Parvovirus B19: What Is the Relevance in Transfusion Medicine?

4. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensuring Transfusion Safety: Screening Blood Donors for Human Parvovirus B19;Cureus;2024-08-21

2. Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review;Transplant Infectious Disease;2023-02-07

3. The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review;Medical Decision Making;2021-10-25

4. Transfusion‐Transmitted Diseases;Transfusion Medicine;2021-03-02

5. Parvovirus B19 and recipient safety: is it time to do more?;Transfusion Medicine;2020-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3